SAM
ANIP icon

Shell Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Shell Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,644
Closed -$106K – 1256
2022
Q4 		$106K Sell
2,644
-596
-18% -$22.4K ﹤0.01% 1142
2022
Q3 		$104K Sell
3,240
-841
-21% -$28.8K ﹤0.01% 1220
2022
Q2 		$121K Buy
4,081
+12
+0.3% +$346 ﹤0.01% 1238
2022
Q1 		$114K Sell
4,069
-599
-13% -$22.3K ﹤0.01% 1272
2021
Q4 		$215K Buy
4,668
+16
+0.3% +$688 ﹤0.01% 1191
2021
Q3 		$153K Sell
4,652
-170
-4% -$5.29K ﹤0.01% 1247
2021
Q2 		$169K Buy
4,822
+260
+6% +$8.85K ﹤0.01% 1271
2021
Q1 		$165K Buy
+4,562
New +$143K ﹤0.01% 1190

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Shell Asset Management's ANIP Position: Q1 2023 in Review

Shell Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2023, closing a stake of 2,644 shares — an estimated $106K sold.

Shell Asset Management first reported a position in ANIP in Q1 2021 and held it in 8 quarters. The position peaked at $215K in Q4 2021. 138 funds tracked by Wall St. Rank hold ANIP as of Q1 2023.

  • Shell Asset Management reported no remaining ANI Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Shell Asset Management sold 2,644 ANI Pharmaceuticals shares in Q1 2023, an estimated $106K.
  • Shell Asset Management first reported a position in ANI Pharmaceuticals in Q1 2021 and held it in 8 quarters.
  • Shell Asset Management's ANI Pharmaceuticals position peaked at $215K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2023.

Based on Shell Asset Management's 13F filing for Q1 2023, filed 15 May 2023.